Zobrazeno 1 - 10
of 815
pro vyhledávání: '"Matthew R Cooperberg"'
Autor:
Martin Lajous, Matthew R Cooperberg, Jennifer Rider, Hugo Arturo Manzanilla-García, Fernando Bernardo Gabilondo-Navarro, Francisco Tomás Rodríguez-Covarrubias, Ruy López-Ridaura, Luisa Elvira Torres-Sánchez, Alejandro Mohar
Publikováno v:
Salud Pública de México, Vol 61, Iss 4, jul-ago, Pp 542-544 (2019)
Prostate-specific antigen (PSA)-based early detection for prostate cancer is the subject of intense debate. Implementation of organized prostate cancer screening has been challenging, in part because the PSA test is so amenable to opportunistic scree
Externí odkaz:
https://doaj.org/article/09f180ed76c341938db3d5792263355d
Autor:
Michael S Leapman, Antonio C Westphalen, Niloufar Ameli, H Jeffrey Lawrence, Phillip G Febbo, Matthew R Cooperberg, Peter R Carroll
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0185535 (2017)
We aimed to directly compare results from multi-parametric prostate MRI (mpMRI) and a biopsy-based 17-gene RT-PCR assay providing a Genomic Prostate Score (GPS) among individuals who were candidates for active surveillance with low and intermediate r
Externí odkaz:
https://doaj.org/article/8a760b025e2d486fb847de4c34c0cd3e
Autor:
Ryan Sutherland, Cary P. Gross, Xiaomei Ma, Farah Jeong, Tyler M. Seibert, Matthew R. Cooperberg, William J. Catalona, Shellie D. Ellis, Stacy Loeb, Dena Schulman‐Green, Michael S. Leapman
Publikováno v:
BJUI Compass, Vol 5, Iss 6, Pp 593-601 (2024)
Abstract Introduction Although prostate magnetic resonance imaging (MRI) is commonly used in the diagnosis, staging and active surveillance of prostate cancer, little is known about patient perspectives on MRI. Methods We performed a qualitative stud
Externí odkaz:
https://doaj.org/article/a716092646f0417b8cff9026b974b943
Autor:
Siao-Yi Wang, Stephen Shiboski, Cassandra D Belair, Matthew R Cooperberg, Jeffrey P Simko, Hubert Stoppler, Janet Cowan, Peter R Carroll, Robert Blelloch
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98597 (2014)
Serum microRNAs hold great promise as easily accessible and measurable biomarkers of disease. In prostate cancer, serum miRNA signatures have been associated with the presence of disease as well as correlated with previously validated risk models. Ho
Externí odkaz:
https://doaj.org/article/6ffc3d26fee94052b3619d4de68b4319
Patient experiences with tissue‐based genomic testing during active surveillance for prostate cancer
Autor:
Michael S. Leapman, Ryan Sutherland, Cary P. Gross, Xiaomei Ma, Tyler M. Seibert, Matthew R. Cooperberg, William J. Catalona, Stacy Loeb, Dena Schulman‐Green
Publikováno v:
BJUI Compass, Vol 5, Iss 1, Pp 142-149 (2024)
Abstract Background Tissue‐based gene expression (genomic) tests provide estimates of prostate cancer aggressiveness and are increasingly used for patients considering or engaged in active surveillance. However, little is known about patient experi
Externí odkaz:
https://doaj.org/article/a14dc37891e3489084198101c440dd61
Autor:
Alice Guan, Eduardo J. Santiago-Rodríguez, Benjamin I. Chung, Janet K. Shim, Laura Allen, Mei-Chin Kuo, Kathie Lau, Zinnia Loya, James D. Brooks, Iona Cheng, Mindy C. DeRouen, Dominick L. Frosch, Todd Golden, John T. Leppert, Daphne Y. Lichtensztajn, Qian Lu, Debora Oh, Weiva Sieh, Michelle Wadhwa, Matthew R. Cooperberg, Peter R. Carroll, Scarlett L. Gomez, Salma Shariff-Marco
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Patients diagnosed with low-risk prostate cancer (PCa) are confronted with a difficult decision regarding whether to undergo definitive treatment or to pursue an active surveillance protocol. This is potentially further complicate
Externí odkaz:
https://doaj.org/article/aabab07a25854885916d582e6006fec5
Autor:
Jang Hee Han, Annika Herlemann, Samuel L. Washington III, Peter E. Lonergan, Peter R. Carroll, Matthew R. Cooperberg, Chang Wook Jeong
Publikováno v:
The World Journal of Men's Health, Vol 41, Iss 4, Pp 940-950 (2023)
Purpose: Contemporary treatment strategies for localized prostate cancer (PCa) have been evolved over time. However, there is little data regarding survival outcomes based on initial treatment by risk group in this new era. This study aims to evalua
Externí odkaz:
https://doaj.org/article/338559f3a304419f9f29f2f3af3dad7b
Autor:
Samuel L. Washington III, Peter E. Lonergan, Janet E. Cowan, Shoujun Zhao, Jeanette M. Broering, Nynikka R. Palmer, Cameron Hicks, Matthew R. Cooperberg, Peter R. Carroll
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 19234-19244 (2023)
Abstract Introduction We aim to characterize the magnitude of the work burden (weeks off from work) associated with prostate cancer (PCa) treatment over a 10‐year period after PCa diagnosis and identify those at greatest risk. Materials and Methods
Externí odkaz:
https://doaj.org/article/56ad4364eed64abcb3d7370d8bc0a82f
Autor:
Jang Hee Han, Sungyup Lee, Byounghwa Lee, Ock-kee Baek, Samuel L. Washington, Annika Herlemann, Peter E. Lonergan, Peter R. Carroll, Chang Wook Jeong, Matthew R. Cooperberg
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Although there are several decision aids for the treatment of localized prostate cancer (PCa), there are limitations in the consistency and certainty of the information provided. We aimed to better understand the treatment decision process a
Externí odkaz:
https://doaj.org/article/4578e0b672504e5ea491806cad64b0a3
Autor:
Giuseppe Fallara, Daniele Robesti, Daniele Raggi, Francesco Montorsi, Andrea Necchi, Matthew R. Cooperberg, Bernard Malavaud, Guillaume Ploussard, Alberto Martini
Publikováno v:
European Urology Open Science, Vol 52, Iss , Pp 40-43 (2023)
The PROpel trial assessed the combination of olaparib + abiraterone acetate (AA) plus prednisone and androgen deprivation therapy (ADT) versus AA plus prednisone and ADT alone as first-line treatment for metastatic castration-resistant prostate cance
Externí odkaz:
https://doaj.org/article/39ada7f2ca74494fb33cd14f94ba6048